NCCN 2012 Webinar Series: Women’s Health - Management of Hormone Receptor Positive Disease in Breast Cancer
This webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Breast and Ovarian Cancer, collectively known as Women’s Health Cancers. Participants will learn how to implement the NCCN Guidelines recommendations into their practice and gain a clear understanding of the most up-to-date treatment recommendations for these cancers. As research continues in these areas and new information emerges, it is critical that clinicians are kept up-to-date and informed. These webinars will communicate the NCCN Guidelines in a direct and interactive way to community oncologists and other clinical professionals.
This educational program is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.
Following this activity, participants should be able to:
- Discuss the use of gene-based assays to quantify risk of recurrence and help individualize recommendations for adjuvant systemic therapy
- Discuss the value of assessment of biomarkers in recurrent breast cancer
- Discuss the risks and benefits associated with endocrine therapies and optimize selection for treatment of metastatic breast cancer
Robert W. Carlson, MD
Stanford Cancer Institute
- 1.00 Participation
- 1.00 Nurse
- 1.00 Pharmacist
- 1.00 Physician